Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Biocon arm Biocon Pharma secures US FDA nod for generic Liraglutide injection gVictoza
Shares of Biocon Ltd ended at ₹392.70, down by ₹2.65, or 0.67%, on the BSE.
Biocon acquires OCRPS of Biocon Biosphere, Biocon Pharma for ₹315 crore
Shares of Biocon Ltd ended at ₹389.90, up by ₹0.15, or 0.038%, on the BSE.
Stock market today: Trade setup for Nifty 50, Gift Nifty, US-Iran war to gold, silver rates — 7 stocks to buy or sell
Stocks to buy today: Experts have recommended buying these eight shares — UPL, Biocon, HDFC Life, Fortis Healthcare, Tata Technologies, Samman Capital, and MM Forging
Market Trading Guide: ONGC among 2 stocks to buy on Friday for up to 16% returns
Nifty ended sharply lower as US-Iran tensions sparked a broad sell-off, breaking its three-day gain streak. Stock picks include ONGC and Biocon, showing strong bullish momentum on short-term charts. Traders are advised to follow breakout levels with prudent stop-losses.
Stocks to Watch Today: Infosys, Aurobindo Pharma, Swan Defence, Arvind SmartSpaces, Prostarm Info, CleanMax, ICRA, Dredging Corporation in focus on 08 April
Stocks to Watch, 8 Apr: Stocks like Ashiana Housing, Infosys, GAIL India, Aurobindo Pharma, Biocon, Swan Defence and Heavy Industries, Prostarm Info Systems, Arvind SmartSpaces, Clean Max Enviro Energy Solutions, Aditya Birla Capital, Dredging Corporation of India, Aditya Birla Real Estate, and ICRA will be in focus on April 8.
Trade Spotlight: How should you trade Dabur, Max Financial Services, Anthem Biosciences, Biocon, HDFC Bank, and others on May 13?
Technical indicators suggest consolidation and range-bound trading in the market following the recent sharp fall. Below are some short-term trading ideas to consider.
Biocon eyes in-licensing deals to accelerate biosimilars growth
Developing a biosimilar requires years of research and significant capital. In-licensing allows companies to acquire or partner on near-market or approved assets